Linoleic acid
Drug profile
Also known as: alpha-Linoleic acid, linolic acid
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Linoleic acid is a drug catalogued in DrugCentral. DrugCentral lists 17 molecular targets, including FABP3, PPARA and AKR1C3.
- Molecular targets: FABP3, PPARA, AKR1C3 and FABP4 (17 listed in DrugCentral).
- Molecular formula: C18H32O2; molecular weight 280.45 g/mol.
Mechanism & targets
Molecular targets (17)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Fatty acid-binding protein, heart | FABP3 | unknown | Kd 9.70 |
| Peroxisome proliferator-activated receptor alpha | PPARA | unknown | Kd 8.32 |
| Aldo-keto reductase family 1 member C3 | AKR1C3 | unknown | IC50 6.16 |
| Fatty acid-binding protein, adipocyte | FABP4 | unknown | IC50 6.00 |
| Seed linoleate 13S-lipoxygenase-1 | LOX1.1 | unknown | IC50 6.00 |
| Free fatty acid receptor 4 | FFAR4 | agonist | EC50 5.89 |
| Free fatty acid receptor 1 | FFAR1 | agonist | EC50 5.70 |
| Potassium voltage-gated channel subfamily B member 1 | KCNB1 | activator | EC50 5.60 |
| Peroxisome proliferator-activated receptor gamma | PPARG | unknown | IC50 5.21 |
| Peroxisome proliferator-activated receptor delta | PPARD | unknown | IC50 5.00 |
| Prostaglandin G/H synthase 1 | PTGS1 | unknown | IC50 4.89 |
| Tissue factor | F3 | unknown | IC50 4.39 |
| Aromatase | CYP19A1 | unknown | IC50 4.32 |
| Nuclear receptor subfamily 4 group A member 2 | NR4A2 | unknown | Kd 4.30 |
| Adenosine receptor A1 | Adora1 | unknown | IC50 4.19 |
| Prostaglandin G/H synthase 2 | PTGS2 | unknown | IC50 4.03 |
| NAD-dependent protein deacetylase sirtuin-6 | SIRT6 | unknown | EC50 4.00 |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Hepatotoxicity | 155.8 |
| Hepatic necrosis | 147.5 |
| Hepatic encephalopathy | 118.2 |
| Hepatic cirrhosis | 89.2 |
| Drug-induced liver injury | 80.3 |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Linoleic acid is on its molecule page.
| Molecular formula | C18H32O2 |
|---|---|
| Molecular weight | 280.45 g/mol |
| CAS number | 60-33-3 |
| InChIKey | OYHQOLUKZRVURQ-HZJYTTRNSA-N |
| PubChem CID | 5280450 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
How does Linoleic acid work?
Its molecular targets in DrugCentral include FABP3, PPARA, AKR1C3 and FABP4.
What is the chemical formula of Linoleic acid?
Linoleic acid has the molecular formula C18H32O2 and a molecular weight of 280.45 g/mol.
Browse: all drugs starting with L · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 3323 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL267476 — compound record and bioactivity
- PubChem CID 5280450 — chemical identifiers
- DrugBank DB14104 — drug record
- FDA UNII 9KJL21T0QJ — substance identity
- UniProt P05413 (FABP3) — target protein
- UniProt Q07869 (PPARA) — target protein
- UniProt P42330 (AKR1C3) — target protein
- UniProt P15090 (FABP4) — target protein
- UniProt Q5NUL3 (FFAR4) — target protein
- UniProt O14842 (FFAR1) — target protein
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.